首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

1866574

智慧藥丸市場：預測（2025-2030 年）

Smart Pill Market - Forecasts from 2025 to 2030

出版日期: 2025年11月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

智慧藥丸市場規模及預測：

全球智慧藥丸市場規模預計將從 2025 年的 797,842,000 美元成長到 2030 年的 1,454,428,000 美元，複合年成長率為 12.76%。

受藥物輸送和病患監測領域創新技術的推動，智慧藥丸市場正經歷顯著成長，這主要得益於結直腸癌等胃腸道疾病發病率的上升以及對微創醫療解決方案需求的不斷成長。智慧藥丸利用無線醫療技術，為傳統手術和注射提供了創傷較小的替代方案。本分析概述了2023-2025年期間的關鍵市場趨勢、動態、細分和競爭考察，並重點關注2022年以後的發展。

市場促進因素與限制因素

智慧藥丸市場的主要驅動力是胃腸道疾病發病率的不斷上升，這促使人們對智慧藥丸等先進的診斷和治療解決方案的需求日益成長。微創手術的普及以及從疼痛的注射治療轉向無痛的智慧藥丸替代方案，顯著推動了市場需求。無線醫療系統的技術進步，以及將注射藥物重新設計成片劑形式的研發合作不斷增加，也進一步促進了市場成長。然而，高昂的研發和實施成本，以及對病患資料隱私和安全的擔憂，是阻礙智慧藥丸在注重隱私的市場中普及的主要因素。

市場機會與科技應用

智慧藥丸市場蘊藏著巨大的機會，尤其是在醫療保健投資不斷成長的地區。生命週期分析表明，無線通訊和感測器技術的創新正在推動智慧藥丸的廣泛應用。在慢性病管理領域拓展應用，以及加強資料加密以解決隱私問題，都存在著巨大的發展機會。持續的研發夥伴關係正在透過提高智慧藥丸在藥物輸送和病患監測方面的準確性和功能性，進一步擴大技術的滲透率。

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 其他
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 台灣
- 泰國
- 印尼
- 其他

第10章競爭格局與分析

主要企業和策略分析
市佔率分析
併購、協議和合作
競爭對手儀錶板

第11章：公司簡介

Medtronic
Proteus Digital Health
Rani Therapeutics
Medimetrics SA de CV
Otsuka America Pharmaceutical, Inc.
CapsoVision Inc.
Koninklijke Philips NV
Olympus Corporation
Bio-Images Research Limited
Novartis AG

第12章調查方法

簡介目錄

Product Code: KSI061613013

Smart Pill Market Size & Forecast:

The Smart Pill Market is set to increase from USD 797.842 million in 2025 to USD 1,454.428 million by 2030, fueled by a 12.76% CAGR.

The smart pill market, driven by innovative technologies for drug delivery and patient monitoring, is experiencing significant growth due to the rising prevalence of gastrointestinal diseases, such as colon cancer, and increasing demand for minimally invasive medical solutions. Smart pills, which leverage wireless health technologies, offer a less invasive alternative to traditional surgeries and injections. This analysis outlines key market trends, dynamics, segmentation, and competitive insights for the period from 2023 to 2025, focusing solely on developments post-2022.

Market Drivers and Restraints

The primary driver of the smart pill market is the growing incidence of gastrointestinal disorders, which has heightened the need for advanced diagnostic and therapeutic solutions like smart pills. The shift toward minimally invasive procedures and the replacement of painful injections with painless, smart pill-based alternatives are significantly boosting market demand. Technological advancements in wireless health systems, coupled with increased research and development (R&D) collaborations to reformulate injectable drugs into pill form, are further propelling growth. However, high development and deployment costs, alongside concerns over patient data privacy and security, pose notable restraints, potentially limiting adoption in privacy-sensitive markets.

Market Opportunities and Technology Penetration

The smart pill market presents substantial opportunities, particularly in regions with rising healthcare investments. Lifecycle analysis indicates that smart pills are transitioning toward broader adoption, driven by innovations in wireless communication and sensor technologies. Opportunities exist in expanding applications for chronic disease management and enhancing data encryption to address privacy concerns. Ongoing R&D partnerships are deepening technology penetration by improving the precision and functionality of smart pills for both drug delivery and patient monitoring.

Market Segmentation

The smart pill market is segmented by application and geography. Applications are categorized into drug delivery and patient monitoring, with drug delivery leading due to its role in targeted therapies for gastrointestinal conditions. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The report provides detailed forecasts for major countries across these regions, highlighting unique trends and opportunities for manufacturers to address growing healthcare demands.

Regional Analysis

North America holds a leading position in the smart pill market, driven by advanced healthcare infrastructure and high adoption of innovative medical technologies. Europe follows, supported by strong regulatory frameworks and increasing focus on non-invasive treatments. Asia Pacific is a high-growth region, fueled by rising healthcare expenditures and growing awareness of smart pill benefits. South America and the Middle East and Africa are emerging markets, with opportunities tied to improving healthcare access and infrastructure development.

Competitive Landscape

Major players in the smart pill market are focusing on innovation, strategic partnerships, and acquisitions to strengthen their market presence. The analysis details competitive strategies, financial performance from 2023 to 2025, and recent developments, including new product launches with enhanced sensor capabilities and collaborations to expand smart pill applications. The report also covers mergers, acquisitions, and investments made in the past year, reflecting efforts to address evolving healthcare needs.

The smart pill market is poised for robust growth through 2025, driven by rising disease prevalence, technological advancements, and demand for minimally invasive solutions, though tempered by cost and privacy challenges. Regional opportunities and competitive strategies will shape the market's evolution, offering manufacturers avenues for innovation and expansion.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Smart Pill Market Segmentation:

By Product Type

Diagnostic Smart Pills
Therapeutic Smart Pills
Monitoring Smart Pills

By Application

Gastrointestinal Disorders
Oncology
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Others

By End-Use

Hospital & Clinics
Ambulatory Surgical Centers
Home Healthcare Settings
Diagnostic Laboratories

By Technology

Ingestible Cameras
Chemical Sensors
Wireless Communication Systems
Microelectronics and Sensor Integration

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Taiwan
Thailand
Indonesia
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SMART PILL MARKET BY PRODUCT TYPE

5.1. Introduction
5.2. Diagnostic Smart Pills
5.3. Therapeutic Smart Pills
5.4. Monitoring Smart Pills

6. SMART PILL MARKET BY APPLICATION

6.1. Introduction
6.2. Gastrointestinal Disorders
6.3. Oncology
6.4. Cardiovascular Diseases
6.5. Neurological Disorders
6.6. Infectious Diseases
6.7. Others

7. SMART PILL MARKET BY END-USE

7.1. Introduction
7.2. Hospital & Clinics
7.3. Ambulatory Surgical Centers
7.4. Home Healthacre Settings
7.5. Diagnostic Laboratories

8. SMART PILL MARKET BY TECHNOLOGY

8.1. Introduction
8.2. Ingestible Cameras
8.3. Chemical Sensors
8.4. Wireless Communication Systems
8.5. Microelectronics and Sensor Integration

9. SMART PILL MARKET BY GEOGRAPHY

9.1. Introduction
9.2. North America
- 9.2.1. USA
- 9.2.2. Canada
- 9.2.3. Mexico
9.3. South America
- 9.3.1. Brazil
- 9.3.2. Argentina
- 9.3.3. Others
9.4. Europe
- 9.4.1. United Kingdom
- 9.4.2. Germany
- 9.4.3. France
- 9.4.4. Italy
- 9.4.5. Spain
- 9.4.6. Others
9.5. Middle East and Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. Others
9.6. Asia Pacific
- 9.6.1. China
- 9.6.2. Japan
- 9.6.3. India
- 9.6.4. South Korea
- 9.6.5. Taiwan
- 9.6.6. Thailand
- 9.6.7. Indosneisa
- 9.6.8. Others